Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pliant Therapeutics
Biotech
Pliant liver disease med passes high-dose test but doesn't wow
Pliant plans to take phase 2 data of its liver disease treatment to regulators for advice on next steps.
Max Bayer
Feb 5, 2024 10:40am
Google DeepMind vet to join GSK—Chutes & Ladders
Oct 20, 2023 9:30am
Pliant's stock up on early evidence of liver disease efficacy
Sep 26, 2023 9:55am
Novartis punts NASH prospect amid pipeline prioritization pivot
Feb 24, 2023 5:07am
Chasing Boehringer, Pliant sends stock soaring with IPF data
Jan 23, 2023 6:30am
Pliant surges as phase 2 data raise hopes for lung disease asset
Jul 11, 2022 9:25am
